NextCure Inc. (NXTC)
NASDAQ: NXTCHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 8, 11:14 AM ET
NXTC stock chart
Technical analysisKey statistics
All statistics- Market cap
- $28.91M
- EPS (TTM)
- -$8.71
- Dividend yield
- None
- 52-week range
- 1.55 – 15.74
- Day range
- 6.05 – 6.54
- Volume / Avg
- 8.30K / 2.11M
- Beta
- —
- Shares outstanding
- 4.58M
- Next earnings
- Nov 4, 2026
52-week range
NXTC stock today
NextCure (NXTC) is trading at $6.32 on Oct 8, down 3.71% (-$0.245), versus the S&P 500's 0.36% decline. Shares are 59.9% below their 52-week high of $15.74, set on Nov 24, 2025 and 307.4% above the 52-week low of $1.55, in the middle of the past year's range. NXTC is down 53.8% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 7.1%.
NextCure has posted a net loss over the last twelve months (EPS of -$8.71), so its P/E ratio is not meaningful. NextCure's next earnings report is expected on Nov 4, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About NextCure
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- IPO year
- 2019
Earnings
Earnings history- Next report
- Nov 4, 2026
- EPS estimate
- $-0.90
NextCure peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| RNAZTransCode Therapeutics Inc. | 1.74 | -1.31% | $29.41M | vs NXTC |
| GRDXGridAI Technologies Corp. | 4.34 | +5.34% | $30.95M | vs NXTC |
| IGCIGC Pharma Inc. | 0.2799 | -0.04% | $28.94M | vs NXTC |
| MIRAMIRA Pharmaceuticals Inc. | 0.6848 | -3.55% | $28.78M | vs NXTC |
| CNTXContext Therapeutics Inc. | 0.3105 | -0.67% | $28.53M | vs NXTC |
| IMMPImmutep Limited ADR | 3.85 | -6.43% | $28.33M | vs NXTC |
| RMTIRockwell Medical Inc. | 8.22 | 0.00% | $33.13M | vs NXTC |
| ABVCABVC BioPharma Inc. | 0.993 | -0.70% | $26.51M | vs NXTC |
Indexes, lists and sector
NextCure stock FAQ
What is NextCure's stock price today?
NXTC last traded at $6.32 as of Oct 8, 11:14 AM EDT, down 3.71% on the day. Prices are delayed at least 15 minutes.
Does NextCure pay a dividend?
No. NextCure does not currently pay a regular cash dividend.
When is NextCure's next earnings date?
NextCure is expected to report earnings on Wednesday, November 4, 2026. Analysts expect EPS of $-0.90.
Has NXTC ever split its stock?
Yes. The most recent NXTC stock split was a 1-for-12 split on Jul 14, 2025.
What is the NXTC 52-week high?
The 52-week high for NXTC is $15.74 and the 52-week low is $1.55. The stock is currently 59.9% below its high.